Hydrea
Term · Oncology and biomedicine · MLC-T-ONC-004035
A drug that contains the active ingredient hydroxyurea and is used alone or with other anticancer drugs or radiation therapy to treat certain types of chronic myelogenous leukemia and head and neck cancer. It is also being studied in the treatment of other conditions and types of cancer. Hydrea stops cells from making DNA and may kill cancer cells. It may also make cancer cells easier to kill with radiation therapy. Hydrea is a type of antimetabolite.
| Identifier | MLC-T-ONC-004035 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004035",
"term": "Hydrea",
"field": "Oncology and biomedicine",
"definition": "A drug that contains the active ingredient hydroxyurea and is used alone or with other anticancer drugs or radiation therapy to treat certain types of chronic myelogenous leukemia and head and neck cancer. It is also being studied in the treatment of other conditions and types of cancer. Hydrea stops cells from making DNA and may kill cancer cells. It may also make cancer cells easier to kill with radiation therapy. Hydrea is a type of antimetabolite.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/hydrea/"
}
Record 8,786 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.